Clinical Trials
4 trialsNCT02303262 2019-01-29
SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
Sarcoma Alliance for Research through Collaboration
Phase 2 Completed
NCT02236195 2017-09-01
Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes
Mirati Therapeutics Inc.
Phase 2 Completed
NCT00359086 2015-07-01
Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma
Mirati Therapeutics Inc.
Phase 2 Completed
NCT00431873 2015-07-01
A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia
Mirati Therapeutics Inc.
Phase 2 Completed